Eligo Bioscience S.A.S
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $45M
Investors
- 4
About Eligo Bioscience S.A.S
S operates as a biotechnology platform that develops antibiotics for bacteria-associated diseases and precision microbiome engineering.
Who invested in Eligo Bioscience S.A.S
4 investors across 3 rounds
See all investors in Eligo Bioscience S.A.S
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eligo Bioscience S.A.S
Who invested in Eligo Bioscience S.A.S?
Eligo Bioscience S.A.S has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eligo Bioscience S.A.S raised?
Eligo Bioscience S.A.S has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Eligo Bioscience S.A.S last raise money?
Eligo Bioscience S.A.S's most recent round on record is a Series B, in Dec 2023.
What does Eligo Bioscience S.A.S do?
S operates as a biotechnology platform that develops antibiotics for bacteria-associated diseases and precision microbiome engineering.
Where is Eligo Bioscience S.A.S headquartered?
Eligo Bioscience S.A.S is headquartered in Paris, France.
Which VCs invest in companies like Eligo Bioscience S.A.S?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Eligo Bioscience S.A.S's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Eligo Bioscience S.A.S? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.